In the mid-19th century, Gerson von Bleichröder gained fame as the financial advisor to Otto von Bismarck, the Chancellor of the German Empire. The investment firm S. Bleichröder merged with Arhnold Bros. in 1964, eventually becoming New-York City-based Arnhold and S. Bleichroeder, Inc. That firm was renamed First Eagle Investment...
GE is another Enron, only worse. That's according to forensic accountant Harry Markopolos, famous for raising red flags about Bernie Madoff ’s Ponzi scheme before most anyone else had a clue. Markipolos released a report on Thursday claiming General Electric (GE) has been...
Donald Trump's insider buying history is short, but interesting, given the fact that the former corporate insider is now the 45th President of the United States. It was Monday, Sept. 15, 2008 at 3:08 PM when Donald J. Trump filed a Form 4...
Hudson Executive Capital disclosed on Monday that it bought 143,200 shares of USA Technology (USAT) at $4.46 along with call options giving the fund the right to buy another 1,250,000 shares of stock at $10. The call options expire on Jan. 17, 2020.
The insider trading anomaly was first formally identified by James Lorie and Victor Niederhoffer in a 1968 article Predictive and Statistical Properties of Insider Trading. Much has changed in the investment markets over the ensuing years. But the predictive properties of insider trading remain as relevant today...
Bill Gurley's Stitch Fix insider buying is his first ever as a corporate insider. Gurley bought $3.1 million of Stitch Fix, Inc. (SFIX) shares on the open market, increasing his personal stake by 25% to 755,000 shares. The tech dealmaker's purchases come as SFIX short interest has...
Billionaire John Malone's insider buying may be rare, but when he does make a purchase, it pays to join him. On May 15, Malone along with two other Qurate Retail Inc. (QRTEA) insiders, bought over $14 million of the retailing and media stock at an average price...
Myriad Genetics co-founder Walter Gilbert PhD bought $150K of MYGN on Dec. 13 @ $25.60. Gilbert, who won the Nobel Prize for Chemistry in 1980, has a history of Form 4 filings at Myriad dating back to 2006. However, this is the insider's first open market purchase...
"Insiders are selling stock like it's 2007." That's a headline from August 27, 2019. Sounds ominous. One might have been inclined to think: The smart guys are dumping stock, guess I should too. Well that would have been a big mistake. Since that headline was posted, the...
Protagonist Therapeutics insiders bought on Tuesday as their company's stock plummeted after preliminary data appeared to cast doubt on Protagonist's (PGTX) key drug. On Monday, the company presented an initial look at preliminary results from the TRANSCEND Ph2 open-label study of PTG-300 (hepcidin...